Hypercalcemia is the most common metabolic complication of breast cancer [1]. Frequency of hypercalcemia in patients with breast cancer has been reported as high as 30–40% [2, 3]. Metastatic bone disease is the main reason for hypercalcemia in these patients [2, 4]. Other possible mechanisms are...
Breast cancer is one of the most prevalent malignancies and exhibits a significantly higher incidence in the female population compared to other types of cancer [1]. Over the past decade, the incidence of breast cancer has been on the rise in most Asian countries [2, 3]. During the course of treatment,...
Breast cancer(BC) has surpassed lung cancer to become the most common female tumor in the world. According to the data in 2020, it is estimated that there have been 2,300,000 new cases of BC (11.7%) worldwide, and BC is also the leading cause of cancer-related death, according to the statistics, 684,699...
With over 2.3 million incident cases diagnosed each year, breast cancer is the most common malignancy in women worldwide [1]. In western countries, 10-year survival after breast cancer is around 75% and increasing, due to widespread adoption of mammography screening and advancements in treatment efficacy...